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Abstract 
Background-Right ventricular (RV) enlargement and dysfunction are strongly 
associated with prognosis in humans with pulmonary hypertension (PH). Reference 
intervals for RV size and systolic function have been described in healthy dogs.  
Objectives-To assess RV size and systolic function in dogs with PH and verify if they 
are associated with disease severity and right-sided congestive heart failure (R-CHF). 
Animals-89 dogs with PH, and 74 healthy dogs. 
Methods-Prospective observational study. PH was classified according to tricuspid 
regurgitation pressure gradient. RV end-diastolic area (RVEDA) index was calculated as 
RVEDA divided by body surface area. RV systolic function was assessed with the 
tricuspid annular plane systolic excursion (TAPSE) and the RV fractional area change 
(FAC) normalized for body weight (TAPSEn and FACn, respectively). 
Results-RVEDA index was higher in dogs with moderate and severe PH than in those 
with mild PH and control dogs (P<0.001 for each contrast). RVEDA index was 
significantly higher in dogs with R-CHF than in dogs without R-CHF (P<0.001). The 
severity of tricuspid regurgitation (TR) was the only independent predictor of RVEDA 
index. TAPSEn and FACn were not significantly different among degrees of PH severity 
and between dogs with and without R-CHF. 
Conclusions and Clinical Importance-The RVEDA index can be used to evaluate RV 
size in dogs. It may provide complementary information in dogs with PH and predict R-
CHF. TR is the main determinant of RV enlargement in dogs with PH. RV systolic 
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function, assessed with TAPSEn and FACn, does not seem to be a predictor of R-CHF 
in dogs with PH. 
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Introduction 
Pulmonary hypertension (PH) in dogs is associated with various conditions, such as 
idiopathic pulmonary arterial hypertension, pulmonary diseases, heartworm disease, 
thromboembolic diseases, and congenital or acquired cardiac diseases (Kellihan 2010). 
Chronic PH can lead to changes of the right heart, including right ventricular (RV) 
hypertrophy, dilatation and RV dysfunction, eventually evolving to right-sided congestive 
heart failure (R-CHF) (Gaynor 2005; Vonk-Noordegraaf 2013). RV enlargement and 
systolic dysfunction are strongly associated with poor prognosis in humans (Ghio 2001; 
Van Wolferen 2007; Brierre 2010; Ghio 2011, Kassem 2013; Grünig 2015). 
Transthoracic echocardiography is the main non-invasive method for the diagnosis of 
PH both in humans and in dogs (Bossone 2013, Kellihan 2010). In humans, RV size and 
function are quantitatively assessed mainly using M-mode, 2-dimensional (2D), 3-
dimensional (3D), and Doppler echocardiography (Rudsky 2010; Kossaify 2015; Lang 
2015). 3D echocardiography is the most accurate method to evaluate RV size, however 
it is time-consuming, not readily available, and the equipment cost is high. Thus, in 
clinical practice, 2D evaluation of linear and area dimensions of the RV are the most 
practical used parameters to assessed RV size (Rudsky 2010, Lang 2015, Marra 2015, 
Kossaify 2015, Gentile-Solomon 2016, Vezzosi 2018). Also for the assessment of RV 
systolic function, 3D echocardiography is the gold standard non-invasive tool. However, 
the tricuspid annular plane systolic excursion (TAPSE) and the fractional area change 
(FAC) are commonly used parameters of RV systolic function in clinical practice 
(Anavekar 2007, Rudsky 2010, Kossaify 2015, Visser 2017). 
In dogs with PH, RV size and function has been traditionally assessed by only subjective 
and/or M-mode evaluation (Pariaut 2012; Tidholm 2015; Borgarelli 2015; Visser 2016; 
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Poser 2017). However, in humans, 2D echocardiography is considered more accurate 
than M-mode in the assessment of RV size and function, and the subjective approach is 
relatively inaccurate (Rudsky 2010; Ling 2012; Kossaify 2015; Grünig Eur Resp Rev 
2015; Lang 2015). Recently, reference ranges for the quantitative assessment (M-mode 
and 2D) of RV size and function in healthy dogs has been proposed, and weight-specific 
reference intervals provided (Visser 2015; Gentile-Solomon 2016).  
The aim of this study was to evaluate the RV end-diastolic area (RVEDA) as a 2-
dimensional indicator of RV size, and TAPSE and FAC as indexes of RV systolic 
function in dogs with PH.  The hypothesis was that RV size increases with both severity 
of PH and tricuspid regurgitation (TR), and that RV size is a predictor of R-CHF. In 
addition, we hypothesized that RV systolic function decreases with the severity of PH. 
 
Materials and methods 
The investigation was prospective, multicenter and observational. The study protocol 
was reviewed and approved by the Institutional Welfare and Ethics Committee of the 
University of Pisa (permission number 38/2015). 
 
Animals 
Over a 2-year period, client-owned dogs affected by PH or clinically healthy were 
prospectively included. Dogs were clinically healthy based on the absence of complaints 
and unremarkable physical, cardiovascular assessment and transthoracic 
echocardiogram. Dogs had PH if during echocardiography a tricuspid regurgitation 
pressure gradient (TRPG) ≥ 36 mmHg was identified (Johnson 1999, Borgarelli 2015, 
Visser 2016). The TR jet velocity was measured by continuous-wave Doppler from the 
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view that allowed the best alignment with the direction of the jet. The TRPG was derived 
from the peak systolic tricuspid regurgitation jet velocity via the simplified Bernoulli 
equation (PG = 4 x velocity2). Dogs with PH were divided into 3 groups: mild PH if TRPG 
was 36– 50 mmHg, moderate PH if TRPG was 51–75 mmHg and severe PH if TRPG 
was >75 mmHg. Dogs with PH were divided into 2 subgroups, namely pre-capillary and 
post-capillary, according to history, physical examination, complete blood count, 
biochemical profile, urinalysis, heartworm test, thoracic radiography, echocardiography, 
abdominal ultrasound and, if necessary, computed tomography, bronchoscopy and 
bronchoalveolar lavage, as previously described (Kellihan 2010, Galiè 2016). The 
presence of R-CHF was based on the presence of ascites associated with jugular 
venous distension, hepatomegaly and a subjectively dilated caudal vena cava. 
Exclusion criteria for this study were the identification of a congenital heart disease, 
acquired cardiomyopathies, pericardial disease, atrial fibrillation and breeds typically 
prone to arrhythmogenic right ventricular cardiomyopathy (Boxers and Bulldogs). In 
addition, all dogs receiving sildenafil or pimobendan were excluded from the study, due 
to the potential influence of these drugs on TRPG and RV systolic function (Visser 
2015B; Sato 2016). 
 
Echocardiographic assessment 
All examinations were performed by 3 experienced operators (T.V., L.V., O.D.). Awake 
dogs were examined in right and left lateral recumbency. Each dog underwent a 
complete echocardiographic examination, which included transthoracic 2D, M-mode, 
spectral and color flow Doppler imaging (Thomas 1993). In all dogs, the 
echocardiographic characterization of the RV was obtained from the left apical 4-
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chamber view optimized for the right heart (Rudsky 2010, Visser 2015, Gentile-Solomon 
2016). RVEDA was measured by planimetry at the end of ventricular diastole, tracing 
from the lateral aspect of the tricuspid annulus to the septal aspect, excluding the area 
of the annulus and trabecular structures, following the RV endocardium (Fig. 1) (Rudsky 
2010, Lang 2015). RVEDA index was calculated as the ratio of RVEDA and body 
surface area (BSA) (Lang 2015). The TAPSE was measured from M-mode recording of 
lateral aspect of the tricuspid valve annulus seen from left apical 4-chamber view 
optimized for the right heart (Rudsky 2010, Visser 2015). The fractional area change 
(FAC) was derived from RV chamber areas using the formula: FAC = [(RV diastolic area 
- RV systolic area) / RV diastolic area] x 100 (Rudsky 2010, Visser 2015). Normalized 
FAC and TAPSE (FACn and TAPSEn) were calculated as the ratio of FAC or TAPSE and 
body weight (BW) using allometric scaling (TAPSEn=TAPSE/BW0.297 and 
FACn=FAC/BW-0.097, respectively) (Visser 2015). TR severity was evaluated qualitatively, 
using the color Doppler and the continuous wave Doppler of the TR jet. Briefly, TR was 
considered mild when a small TR jet on the color Doppler and a faint parabolic TR jet 
signal on the continuous wave Doppler were detected. Moderate TR was considered 
when an intermediate TR jet on the color Doppler and a dense parabolic TR jet signal on 
the continuous wave Doppler were present. Severe TR was considered when a very 
large central jet or eccentric wall impinging jet on the color Doppler and a dense 
triangular with early peaking TR jet signal on the continuous wave Doppler were present 
(Lancellotti 2010). 
The echocardiographic images were stored as digital data for later analysis. All 
measurements were performed offline by the same operator (T.V.) evaluating 3 cardiac 
cycles, and mean values were calculated. 
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Statistical analysis 
Statistical analysis was performed with a commercially available statistical softwarea. 
Descriptive statistics were generated. The normality of data distribution was tested using 
the Shapiro-Wilk test and parametric or non-parametric tests were used according to the 
Gaussian distribution. Linear regression was used to evaluate relationships between 
RVEDA and BSA. The chi-squared or Fisher’s exact tests were used to compare 
categorical variables. Continuous variables were compared using the unpaired t test or 
the Mann-Whitney U-test, based on data distribution. Differences in echocardiographic 
continuous data among PH groups were determined by 1-way analysis of variance with 
subsequent pair-wise comparisons using Tukey’s multiple comparisons test (for normally 
distributed data) or by the Kruskal-Wallis test with subsequent pair-wise comparisons 
using the Dunn test (for non-normally distributed data). In addition, receiver operating 
characteristic curve analysis was used to identify the best diagnostic cut-off of the 
RVEDA index to identify R-CHF, and the optimal combination of sensitivity and 
specificity was determined using the Youden index. 
In dogs with PH, simple (univariate) linear regression analyses were performed to 
determine the strength of association of selected clinical (age, sex, heart rate) and 
echocardiographic indices (TRPG, TR severity) with the RVEDA index. Multiple linear 
regression analysis was used to identify significant independent predictors of the 
RVEDA index. The variables were entered into a multiple linear regression model in a 
backward stepwise manner if P was <0.2 based on univariate linear regression analysis. 
Finally, to verify the applicability of the RVEDA, TAPSE and FAC in a clinical setting, 
intra- and inter-observer measurement variability were determined with the coefficient of 
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variation (CV). For the intra-observer variability, 1 operator (T.V.) calculated RVEDA, 
TAPSE and FAC from 6 randomly selected echocardiographic studies on 2 different 
occasions separated by 30 days. The inter-observer variability was carried out by 2 
operators (T.V., O.D.) measuring the RVEDA, TAPSE and FAC from 6 randomly selected 
blinded echocardiographic studies. A value of P<0.05 was considered statistically 
significant. 
 
Results 
Study population 
A total of 163 dogs of different breeds were included, 89 dogs with PH and 74 healthy 
dogs. Baseline clinical and echocardiographic characteristics of all dogs are shown in 
table 1. Dogs with PH were significantly older than controls (P<0.001) and had a lower 
BW (P<0.001). Regarding sex, no differences were found between dogs with PH and 
healthy controls (P=0.161). 
In the PH group, 25 dogs had mild PH, 25 had moderate PH, and 39 had severe PH. R-
CHF was present in 22 dogs, 8 with moderate PH and 14 with severe PH. Fifty-eight 
dogs had pre-capillary PH (65.2%) and 31 dogs had post-capillary PH (34.8%), with all 
dogs with post-capillary PH affected by myxomatous mitral valve disease. Regarding 
etiology, dogs with pre-capillary PH were affected by heartworm disease (n=21), 
idiopathic PH (n=12), pulmonary fibrosis (n=7), angiostrongylosis (n=5), chronic 
bronchitis (n=5), heart base tumor (n=4) and chronic pulmonary thromboembolism 
(n=4). Dogs with precapillary PH had a higher TRPG in comparison to post-capillary PH 
(P<0.05; table 2). 
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Right ventricular size 
RVEDA showed a strong positive linear correlation with BSA in healthy dogs (r=0.913; 
r2=0.859; P<0.001). The 95% reference range of the RVEDA index in heathy dogs was 
4.9-10.9 cm2/m2. No differences in RVEDA index were found between dogs with mild PH 
and controls (P=0.982). Conversely, the RVEDA index was significantly higher in dogs 
with moderate and severe PH compared to dogs with mild PH and healthy controls 
(P<0.001; Fig. 2). In the univariate analysis, among the clinical and echocardiographic 
variables, TRPG (P=0.002) and TR severity (P<0.001) showed a positive association 
with the RVEDA index. However, only TR severity maintained a significant (P<0.001) 
and independent association with an increased RVEDA index based on multivariate 
analysis (Table 3). 
RVEDA index was significantly higher in dogs with R-CHF (13.7 cm2/m2; range, 11.0-
21.4 cm2/m2) in comparison to dogs without R-CHF (9.4 cm2/m2, range: 4.8-17.1 cm2/m2; 
P<0.001; Fig. 3). The most accurate cut-off value of RVEDA index in the prediction of R-
CHF was >10.9 cm2/m2, with a sensitivity of 100% and a specificity of 73.1% (Table 4). 
No differences in RVEDA index were found between dogs with pre-capillary and post-
capillary PH (P=0.81). 
 
Right ventricular systolic function 
The TAPSEn and FACn did not significantly differ among dogs with mild, moderate and 
severe PH in comparison to healthy dogs (P=0.544 and P=0.675, respectively). No 
differences in TAPSEn and FACn were found between dogs with R-CHF and dogs 
without R-CHF (P=0.32 and P=0.64, respectively). TAPSEn and FACn were significantly 
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higher in dogs with post-capillary PH compared to dogs with pre-capillary PH (P<0.001 
and P<0.05, respectively) (Table 2). However, even analyzing dogs with pre-capillary 
and post-capillary PH as separated groups, TAPSEn and FACn did not significantly differ 
among dogs with different degree of PH, and between dogs with and without R-CHF. 
 
Tricuspid regurgitation severity 
Among dogs with PH, 35/89 (39.3%) presented mild TR, 26/89 (29.2%) moderate TR 
and 28/89 (31.5%) severe TR. Prevalence of severe TR was significantly higher in dogs 
with moderate and severe PH in comparison to dogs with mild PH (P<0.001; Table 1). 
The TRPG was significantly higher in dogs with moderate and severe TR in comparison 
to dogs with mild TR (P<0.001; Table 5). 
Prevalence of severe TR was higher in dogs with R-CHF (20/22, 90.9%) in comparison 
to dogs without R-CHF (8/67, 11.9%) (P<0.001). Dogs with severe TR presented a 
higher RVEDA index in comparison to dogs with mild and moderate TR (P<0.001). 
TAPSEn and FACn did not significantly differ among dogs with mild, moderate and 
severe TR (P=0.50 and P=0.63, respectively). 
Finally, TR severity was not different between dogs with pre-capillary (mild TR: 25/58, 
43%; moderate TR: 15/58, 26%; severe TR: 18/58, 31%) and post-capillary PH (mild 
TR: 10/31, 32%; moderate TR 11/31, 36%; severe TR: 10/31, 32%) (P=0.20). 
 
Reproducibility of measurements 
Intra-observer and inter-observer measurement variability for RVEDA yielded an 
average CV of 7.4% and 9.1%, respectively. Intra-observer and inter-observer 
measurement variability for TAPSE yielded an average CV of 3.2% and 4.7%, 
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respectively. Intra-observer and inter-observer measurement variability for FAC yielded 
an average CV of 6.6 % and 12.9%, respectively. 
 
Discussion  
The major findings of this prospective study are that (1) RV size, evaluated with RVEDA 
index, increases in dogs with moderate and severe PH and predicts R-CHF, (2) TR 
severity is the only independent determinant of RV size in dogs with PH, (3) RV systolic 
function, assessed with TAPSEn and FACn, does not seem to be a predictor of R-CHF 
in dogs with PH.  
Logic dictates that cross-sectional areas within the heart should correlate positively with 
BSA (proportional to BW2/3). In line with this concept, in our investigation RVEDA 
positively correlated with BSA, showing a very high coefficient of determination 
(r2=0.859). This linear correlation between RVEDA and BSA has already been 
documented in humans, and the normalization of the RVEDA to the BSA is 
recommended to account for the different biometric characteristics of patients 
(D’Oronzio 2012, Willis 2012, Lang 2015). Thus, considering the clinical acceptable 
measurement variability, RVEDA indexed to BSA may be used to objectively evaluate 
RV size in dogs, and we described a normal reference range for this parameter in 
healthy dogs. 
To the authors knowledge, this is the first study using a 2D echocardiographic index of 
RV size in dogs with PH. Similar to previous investigations in humans and in dogs 
(Raymond 2002; Chin 2005; Tidholm 2015; Visser 2016), in our study the RV size 
increases in dogs with moderate-to-severe PH and not in those with mild PH. Differently, 
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a recent study in dogs did not show any differences in RV size in dogs with different 
severity of PH (Poser 2017), but the authors assessed RV size using linear dimensions 
obtained by M-mode. This finding could reflect the inaccuracy of M-mode in the 
assessment of RV size. Differently, another study in dogs reported RV dilation not only in 
moderate-to-severe PH but also in dogs with mild PH (Pariaut 2012). However, in this 
study RV dilation was only based on a subjective-assessment, that is relatively 
inaccurate in comparison to objective-assessment as demonstrated in humans (Rudsky, 
2010; Ling LF, 2012; Kossaify, 2015; Grünig, Eur Resp Rev 2015). In our study, the 
RVEDA index was significantly higher in dogs with R-CHF compared to those without R-
CHF, and a RVEDA index > 10.9 cm2/m2 best predicted R-CHF. In line with our results, a 
previous experimental study in dogs with induced PH by pulmonary artery banding 
described a significant increase in RVEDA in onset R-CHF (Hsieh 1992). This result is in 
accordance with human literature, where RV enlargement is of clinical importance since 
it reflects RV pressure and volume overload and is associated with prognosis in humans 
with PH (van Wolferen 2007; Ghio 2011; Vonk-Noordegraaf 2011; Kassem 2013).   
Multivariate analysis showed that RV size mainly depends on TR severity (volume-
overload) rather than on TRPG (pressure-overload) in dogs with PH. This is in line with 
the literature in humans, where RV size and remodeling in patients with PH have been 
shown to mainly depend on TR severity (Hinderliter 2003, Mutlak 2009). In patients with 
PH, TR is mainly caused by tricuspid annulus dilation and papillary muscle displacement 
secondary to RV remodeling (Hinderliter 2003, Afilalo 2015). The development of TR 
results in RV volume overload and presumably initiates a cycle of progressive annular 
dilation, RV remodeling and worsening of TR (Hinderliter 2003, Mutlak 2009). In 
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addition, considering that almost all dogs with R-CHF exhibited a severe TR in our study, 
we can hypothesize that the severity of the TR is crucial for the development of the R-
CHF rather than RV systolic dysfunction. This is in line with human literature, where TR 
severity is a risk factor for mortality (Koelling 2002, Nath 2004, Mutlak 2009). 
 
TAPSE and FAC are reproducible indices of RV systolic function in veterinary practice 
(Visser 2015). In our study, TAPSEn and FACn did not significantly differ among dogs 
with and without PH, irrespective of severity. Similarly, in our sample population no 
differences in TAPSEn and FACn were found between dogs with and without R-CHF. In 
the veterinary literature, contrasting data are present on RV systolic function in dogs with 
PH. Two studies reported a significant reduction in TAPSE (Pariaut 2012) and FAC 
(Visser 2016) in dogs with severe PH. Differently, in other studies on PH in dogs with 
myxomatous mitral valve disease, TAPSE did not significantly changed with PH severity 
(Tidholm 2015; Poser 2017). Possible reasons for this discrepancy are: different 
reference intervals for TAPSE, different size of sample population, different underlying 
etiology of PH, and possibly different clinical severity among dogs with severe PH. 
Moreover, severe TR may influence Doppler estimation of pulmonary arterial pressure 
(Ozpelit 2015, Fei 2017) and is a significant confounding factor when applying TAPSE to 
assess RV function (Hsiao 2006). As previously shown, TAPSE increases with TR 
severity independent of RV function (Hsiao 2006). So, differences in TR severity among 
studies could potentially influence estimation and interpretation of RV systolic function. 
By our results, dogs with post-capillary PH showed higher RV systolic function 
measurements compared to dogs with pre-capillary PH. Also in previous studies in dogs 
with myxomatous mitral valve disease, TAPSE did not changed with PH severity 
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(Tidholm 2015; Poser 2017). This result could be explained because of the 
hyperdynamic left ventricle in myxomatous mitral valve disease that causes a traction on 
the RV free wall and then a shift of the tricuspid annulus toward the left by the effect of 
the ventricular interdependence (Poser 2017; Chapel 2017). 
The following study limitations should be acknowledged. First, the sample population 
was not homogeneous, in fact, the healthy group was younger and heavier compared to 
the dogs with PH. Second, the body condition score was not evaluated in the study 
population, and since the RVEDA index is calculated using the BSA, the body condition 
score could have influenced this index. Similarly, the presence of ascites could have 
influenced the RVEDA index, however the body weight was always evaluated after 
paracentesis. Third, in our study pulmonary hypertension was classified according to the 
TRPG and not by invasive measurements of pulmonary artery systolic pressures (i.e. 
right heart catheterization), which represents the gold standard. However, quantification 
of the TRPG is currently used by most cardiologists to estimate pulmonary artery 
systolic pressure in small animals (Kellihan 2010). In addition, a TRPG cut-off value of 
36 mmHg was used to diagnose PH in line with the literature (Johnson 1999, Borgarelli 
2015, Visser 2016), however no consensus exists regarding the best echocardiographic 
cut-off to diagnose PH in dogs. Thus, it cannot be ruled out that if a different TRPG cut-
off had been used, our results may have been different. 
In conclusion, the RVEDA index can be used in the quantitative assessment of RV size 
in dogs. It may provide beneficial complementary information in dogs with PH and 
predict R-CHF. TR severity is the main determinant of RV enlargement in dogs with PH, 
and it seems to play a key role in the occurrence of R-CHF. RV systolic function, 
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assessed with TAPSE and FAC, do not seem to be a predictor of R-CHF. Further 
longitudinal studies are needed to evaluate the prognostic role of RVEDA index and to 
evaluated a less load-independent parameters of RV systolic function, like RV strain 
rate, in dogs with PH. 
 
 
Footnotes 
a GraphPad Prism version 5.0 for Windows, GraphPad Software, San Diego, CA. 
b Minitab version 18 for Windows, Minitab Inc, Pennsylvania, PA. 
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Tables 
Table 1. Clinical and echocardiographic data of all study dogs (n = 163). 
 Control Mild PH Moderate PH Severe PH 
N° cases 74 25 25 39 
Sex (male/female) 33/41 15/10 17/8 18/21 
Age (years) 2.9 (1-13) 11.5 (2-15) a 11 (2-16) a 12.2 (1-18) a 
BW (kg) 25.7 (1.8-57) 12.6 (5-41.2) 7.9 (2.7-34) a 10.8 (2.2-40) a 
TRPG (mmHg) 0 (0-25) 44 (37.7-49) a 59.6 (51.8-74) a,b 96 (77-149) a,b,c 
Severe TR 0 (0%) 0 (0%) 8/25 (32%) a,b 20/39 (51%) a,b 
RVEDA index (cm2/m2) 8.5 (2.8-11.6) 8.4 (4.8-11.6) 10.8 (6.2-17.4) a,b 12.4 (7.7-21.4) a,b 
TAPSEn 6.4 (4.8-10.3) 6.3 (4.9-10.1) 6.9 (2.3-10.9) 6.0 (3.1-10.2)  
FACn 62 (47.6-82.1) 61.4 (48.0-99.5) 67.9 (38.6-93.4) 62.8 (22.3-95.8) 
R-CHF 0 (0%) 0 (0%) 8/25 (32%) a,b 14/39 (36%) a,b 
 
Data represent median (min–max) or number (percentage). TRPG, tricuspid 
regurgitation systolic pressure gradient; TR, tricuspid regurgitation; RVEDA, right 
ventricular end-diastolic area; TAPSEn, tricuspid annular plane systolic excursion 
normalized for body weight; FACn, fractional area change normalized for body weight; 
RI, reference interval; R-CHF, right-sided congestive heart failure. 
a P < 0.001 compared to control group. 
b P < 0.001 compared to mild PH group. 
27 
c P < 0.001 compared to moderate PH group. 
 
Table 2. Clinical and echocardiographic data of dogs with pre-capillary and post-
capillary PH. 
 Pre-capillary PH Post-capillary PH  
N° cases 58 31  
TRPG (mmHg) 79 (38-149) 60 (37-96) a  
Severe TR 18 (31%) 10 (32%)  
RVEDA index (cm2/m2) 10.7 (4.8-21.4) 10.6 (6.2-14.8)  
TAPSEn 5.8 (2.3-10.1) 7.9 (3.8-11) b  
FACn 60.6 (22.3-85.5) 65.8 (39.1-97.5) a  
R-CHF 12/58 (20.7%) 10/31 (32.2%)  
 
Data represent median (min–max) or number (percentage). TRPG, tricuspid 
regurgitation systolic pressure gradient; TR, tricuspid regurgitation; RVEDA, right 
ventricular end-diastolic area; TAPSEn, tricuspid annular plane systolic excursion 
normalized for body weight; FACn, fractional area change normalized for body weight; 
RI, reference interval; R-CHF, right-sided congestive heart failure. 
a P < 0.05 compared to pre-capillary group. 
b P < 0.001 compared to pre-capillary group. 
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Table 3. Multivariate analysis of echocardiographic variables used to predict right 
ventricular end-diastolic area index in dogs with pulmonary hypertension. 
Dependent variable Independent variables Β coefficient P-value 
RVEDA index (cm2/m2) TRPG -0.828 0.133 
 TR severity 2.474 <0.0001 
 
RVEDA, right ventricular end-diastolic area; TRPG, tricuspid regurgitation systolic 
pressure gradient; TR, tricuspid regurgitation. 
 
Table 4. Sensitivity and specificity of different cut-off points of RVEDA index for the 
prediction of R-CHF in 89 dogs with PH. 
 AUC 95% CI P Cut-off Se (%) Sp (%) Youden index  
RVEDA index 0.90 0.84-0.96 <0.001 10.9* 100.0 73.1 73.1  
    17.2 18.2 100.0   
 
RVEDA, right ventricular area index; AUC, area under receiver operating characteristic 
curve; Se, sensitivity; Sp, specificity. The value with the asterisk (*) represents the 
clinically significant cut-off, with the least amount of overlap between groups (optimal 
combination of sensitivity and specificity and highest Youden index). 
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Table 5. Clinical and echocardiographic data of dogs with pulmonary hypertension 
according to tricuspid regurgitation severity (n = 89). 
 Mild TR Moderate TR Severe TR  
N° cases 35 26 28  
TRPG (mmHg) 49 (38-139) 75.5 (40-130) a 87.5 (52-149) a  
RVEDA index (cm2/m2) 8.5 (4.8-15.7) 9.7 (6.2-14.5) 13.4 (10.7-21.4) a,b 
 
TAPSEn 6.0 (3.3-10.3) 6.1 (3.4-9.7) 7.2 (2.3-10.9)   
FACn 61.4 (32.7-99.5) 58.7 (22.3-93.4) 65.5 (32.6-95.8) 
 
R-CHF 0 (0%) 2 (8%) 20 (71%) a,b  
 
Data represent median (min–max). TR, tricuspid regurgitation; TRPG, tricuspid 
regurgitation systolic pressure gradient; RVEDA, right ventricular end-diastolic area; 
TAPSEn, tricuspid annular plane systolic excursion normalized for body weight; FACn, 
fractional area change normalized for body weight; R-CHF, right-sided congestive heart 
failure. 
a P < 0.001 compared to mild TR. 
b P < 0.001 compared to moderate TR. 
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Figure legends 
 
Figure 1. Left apical 4-chamber view optimized for the right heart. The right ventricular 
end-diastolic area (RVEDA) was measured by planimetry at the end of ventricular 
diastole. 
 
Figure 2. Box and whiskers plot for right ventricular end-diastolic area (RVEDA) index in 
control dogs in comparison to dogs with different degree of pulmonary hypertension 
(PH). The RVEDA index was significantly higher in dogs with moderate and severe PH 
in comparison to dogs with mild PH and the control group. *(P<0.001). 
 
Figure 3. Box and whiskers plot for right ventricular end-diastolic area (RVEDA) index in 
dogs with and without right-sided congestive heart failure (R-CHF). The RVEDA index 
was significantly higher in dogs with R-CHF in comparison to dogs without R-CHF 
*(P<0.001). 
